Cambridge Nutraceuticals, the Cambridge-based supplement maker focused on clinically tested and easy-to-absorb products, has secured $100K in new investment. The company, founded in 2012, develops supplements like ATERONON HEART+, which saw £12 million in research funding and clinical testing at Cambridge University Hospital NHS Foundation Trust. Its popular TURMERIC+ joint health supplement is now supported by 41 published studies.
The firm sells direct-to-customer in the UK and reaches international purchasers through overseas distributors, with Australia noted as an important market.














